Biogen, Eisai revive plans for Alzheimer’s drug, surprising market
Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer's treatment aducanumab, surprising investors and saying data from more patients in two discontinued studies showed the drug reduced the decline of patients. Reuters Health News
Experienced Veterinarian with a demonstrated history of working in the veterinary medicine. Skilled in GIS and Applied Epidemiology, Vaccines, and Animal Welfare. Strong community and social services professional with a Master’s Degree focused on Veterinary Preventive Medicine. In Charge of Animal Disease Study, and Surveillance Bureau. Expert on Disease Study, Surveillance, Early Warning/Response, Client Training, and Development. Executive Officer for projects avoiding spread of diseases. Works at Iran Veterinary Organization; 2000 - present. Graduated from Veterinary Faculty of Shiraz University, Shiraz, Iran.